Ending the HIV Epidemic: Reaching the Undiagnosed
In this episode, Babafemi Taiwo, MBBS, discusses strategies for reaching people with HIV who are not yet diagnosed. His overview includes:HIV diagnosis by global regionDisparities in serostatus awaren...
24 Elo 202215min
Safety Considerations for HIV Treatments During Pregnancy
In this episode, hear Dr. Jean Rene Anderson and Dr. William Short discuss special factors to consider when selecting HIV treatments during pregnancy, including:Key elements involved in evaluating ARV...
23 Elo 202214min
Linkage to Care for Patients With HDV
You can think of the “D” in HDV as standing for difficult, disadvantaged, and dangerous. Hepatitis delta virus (HDV) is difficult to diagnose, is often diagnosed in disadvantaged patient populations, ...
3 Elo 202222min
Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations
In this episode, an international expert panel shares their thoughts on key considerations at the operational level for incorporating long-acting injectable antiretroviral therapy into the HIV treatme...
2 Elo 202213min
Switching to Long-Acting Cabotegravir Plus Rilpirivine for HIV Treatment: Assessing Candidacy and Patient Counseling
In this episode, an international expert panel shares their thoughts on key steps for switching patients to long-acting injectable cabotegravir plus rilpivirine for HIV treatment, including selecting...
14 Heinä 202217min
First Cohort With HIV: Paving the Path for the Future
In this episode, hear HIV activist Marc Thompson share his perspectives on aging with HIV including: His early experiences after receiving his diagnosisPersisting issues of the HIV epidemic including ...
6 Heinä 202211min
Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from EASL 2022, including:Novel HBV therapeutics, including the REEF-2, B-Clear, and SAVE-1 studiesHBV cure from the Everest Proj...
6 Heinä 202237min
Advancements in Viral Hepatitis From EASL 2022
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from EASL 2022, including:Novel therapeutics for HBVTherapeutic vaccination for HBVEmerging treatment options for HDVHCV care cascad...
5 Heinä 20227min
